Acer Medical Statistics
Total Valuation
Acer Medical has a market cap or net worth of TWD 1.80 billion. The enterprise value is 1.59 billion.
Market Cap | 1.80B |
Enterprise Value | 1.59B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Acer Medical has 15.23 million shares outstanding.
Current Share Class | 15.23M |
Shares Outstanding | 15.23M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 4.78% |
Owned by Institutions (%) | 0.48% |
Float | 3.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 35.82 |
PB Ratio | 9.23 |
P/TBV Ratio | 9.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -58.25 |
EV / Sales | 31.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.84
Current Ratio | 6.84 |
Quick Ratio | 6.66 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.14% and return on invested capital (ROIC) is -9.06%.
Return on Equity (ROE) | -13.14% |
Return on Assets (ROA) | -7.76% |
Return on Invested Capital (ROIC) | -9.06% |
Return on Capital Employed (ROCE) | -15.52% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 22 |
Asset Turnover | 0.21 |
Inventory Turnover | 2.33 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.87% in the last 52 weeks. The beta is 1.23, so Acer Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.23 |
52-Week Price Change | -35.87% |
50-Day Moving Average | 125.85 |
200-Day Moving Average | 142.36 |
Relative Strength Index (RSI) | 40.38 |
Average Volume (20 Days) | 2,188 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acer Medical had revenue of TWD 50.16 million and -27.36 million in losses. Loss per share was -1.80.
Revenue | 50.16M |
Gross Profit | 31.67M |
Operating Income | -30.20M |
Pretax Income | -27.36M |
Net Income | -27.36M |
EBITDA | -29.63M |
EBIT | -30.20M |
Loss Per Share | -1.80 |
Balance Sheet
The company has 202.78 million in cash and n/a in debt, giving a net cash position of 202.78 million or 13.32 per share.
Cash & Cash Equivalents | 202.78M |
Total Debt | n/a |
Net Cash | 202.78M |
Net Cash Per Share | 13.32 |
Equity (Book Value) | 194.59M |
Book Value Per Share | 12.78 |
Working Capital | 188.59M |
Cash Flow
Operating Cash Flow | -20.70M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 63.15%, with operating and profit margins of -60.20% and -54.56%.
Gross Margin | 63.15% |
Operating Margin | -60.20% |
Pretax Margin | -54.56% |
Profit Margin | -54.56% |
EBITDA Margin | -59.06% |
EBIT Margin | -60.20% |
FCF Margin | n/a |
Dividends & Yields
Acer Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1.52% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Acer Medical has an Altman Z-Score of 47.35.
Altman Z-Score | 47.35 |
Piotroski F-Score | n/a |